Mark G. Currie, Chief Scientific Officer at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 120,000 shares at $17.06 ($2.0M) on 2017-03-14, disclosed to the SEC on 2017-03-16.
Open-market sale of $2.0M IRWD by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.06 | 60,000 | $1.0M | 50.0% |
| 2 | $17.06 | 60,000 | $1.0M | 50.0% |
| Total | $17.06 avg | 120,000 | $2.0M | 100% |
| Filing → |
| IRWD | SELL | 2021-06-16 | $546K | — | Filing → |
| CYCN | SELL | 2020-12-30 | $121K | — | Filing → |
| IRWD | SELL | 2020-01-24 | $755K | — | Filing → |